Tiogiva is a brand name for the medication tiotropium bromide, which is commonly used in the treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It belongs to a class of drugs known as long-acting muscarinic antagonists (LAMAs), which work by relaxing the muscles around the airways in the lungs, making it easier to breathe. Tiogiva is administered through inhalation, allowing the medication to directly reach the lungs. It is designed for once-daily use to provide 24-hour relief from the symptoms of COPD. By improving airflow and reducing the likelihood of COPD exacerbations, Tiogiva helps to improve the quality of life for individuals suffering from this chronic respiratory condition.